Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | REN | P00797 | 4/20 | 0.52 |
| ▸ | CTSK | P43235 | 3/20 | 0.49 |
| ▸ | CTSL | P07711 | 4/20 | 0.49 |
| ▸ | CTSS | P25774 | 4/20 | 0.49 |
| ▸ | CTSB | P07858 | 3/20 | 0.49 |
| ▸ | CTSD | P07339 | 1/20 | 0.48 |
| ▸ | TRPM8 | Q7Z2W7 | 1/20 | 0.48 |
| ▸ | TACR1 | P25103 | 1/20 | 0.47 |
| ▸ | CTRB1 | P17538 | 2/20 | 0.46 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.45 |
| ▸ | SPPL2A | Q8TCT8 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6446525 | 0.85 | CTSD (0.60) | RENCTSKCTSLCTSSCTSB | |
| SCHEMBL7330753 | 0.84 | REN (0.49) | RENCTSKCTSLCTSSCTSB | |
| SCHEMBL7332756 | 0.83 | REN (0.48) | RENCTSKCTSLCTSSCTSB | |
| SCHEMBL7328082 | 0.82 | CTSD (0.55) | RENCTSD | |
| SCHEMBL7328076 | 0.82 | CTSD (0.55) | RENCTSD | |
| SCHEMBL7328968 | 0.81 | CTSD (0.54) | RENCTSD | |
| SCHEMBL7320103 | 0.80 | CTSD (0.59) | RENCTSD | |
| SCHEMBL7332296 | 0.79 | CTSD (0.70) | RENCTSKCTSBCTSDTRPM8 | |
| SCHEMBL15095633 | 0.79 | CTSD (0.70) | RENCTSKCTSBCTSDTRPM8 | |
| SCHEMBL7332555 | 0.79 | CTSD (0.58) | RENCTSD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-1039596-A | Preparation method in conjunction with the peptide of retroviral Protease | SMITHKLINE BECKMAN CORP (US) | 1990-02-14 | — | — | CN | disclosed |